TY - JOUR T1 - Potential Predictive Factors for Breast Cancer Subtypes from a North Cyprus Cohort Analysis JF - medRxiv DO - 10.1101/19010181 SP - 19010181 AU - Ayse Ulgen AU - Özlem Gürkut AU - Wentian Li Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/10/29/19010181.abstract N2 - More than three hundreds North Cyprus breast cancer patients with subtype information are surveyed for their demographic, reproductive, genetic, epidemiological factors. Despite the fact that our cohort differs significantly from some larger cohorts (e.g., the Breast Cancer Family Registry (BCFR) with samples from USA/Canada/Australia) in age, menopause status, age of menarche, parity, education level, oral contraceptive use, breast feeding, the distribution of breast subtypes is not significantly different. Using regularized regressions, we show that the estrogen-receptor-positive (ER+) subtype is positively related to post-menopause and negatively associated with hormone therapy; the estrogen-receptor-positive and progesterone-receptor-positive (ER+/PR+) subtype is positively associated with breast feeding, and negatively associated with hormone therapy status. On the other hand, the human epidermal growth factor 2 positive (HER2+) subtype, which itself is negatively correlated with ER+ and ER+/PR+, is positively related to having first-degree-relative with cancer, and negatively associated with post-menopause. Single and multiple regression also identify older age to be positively correlated to ER+ and ER+/PR+ subtypes, and negatively correlated to HER2+ subtype. Assuming ER+ and ER+/PR+ subtypes to have better prognostic, then post-menopause and breast-feeding are beneficial, and hormone therapy treatment is detrimental.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAU was supported by Fullbright Visiting Research Scholarship Grant from the US Department of State.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not Applicableindividual person's data is not available. summary data is available upon request. ER -